Barrington W W, Jacobson K A, Stiles G L
Department of Medicine, Cardiology, Duke University Medical Center, Durham, North Carolina 27710.
Mol Pharmacol. 1990 Aug;38(2):177-83.
Mammalian A2-adenosine receptor binding subunits (A2AR) can be visualized by covalent labeling with the photoaffinity crosslinking ligand 125I-2-[4-[2-[2-[(4-aminophenyl)methylcarbonylamino] ethylaminocarbonyl]ethyl]phenyl]ethylamino-5'-N-ethylcarboxamidoad enosine or directly with the azide derivative described in this paper. The protein comprising the A2-adenosine receptor binding subunit migrates with a Mr of 45,000 on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. In this study, the glycoproteins representing the radiolabeled A1- and A2-adenosine receptor binding subunit from bovine brain were compared by partial peptide maps and following treatment with exo- and endoglycosidases. Peptide maps using two separate proteases reveal that the A1- and A2-adenosine receptor binding subunits share no common peptide fragments by two-dimensional gel electrophoresis. Endoglycosidase F treatment of labeled A2AR results in a single labeled peptide of Mr 38,000 without intermediate peptides, suggesting a single N-linked carbohydrate chain. The labeled A2AR demonstrates a sensitivity to neuraminidase, as evidenced by an increased mobility on gel electrophoresis, suggesting the receptors contain a glycan component containing terminal sialic acid. Treatment of the labeled A2AR with alpha-mannosidase reveals two distinct populations of A2ARs, one of which is sensitive and the other resistant to the enzyme. The nonadditivity of sequential treatments with the two exoglycosidases suggests, a heterogeneous population of A2AR containing either complex- or high mannose-type carbohydrate chains. These data suggest the A2AR is a Mr 45,000 glycoprotein with a single carbohydrate chain of either the complex or high mannose type. In addition, the A1- and A2ARs are distinct glycoproteins, as evidenced by their differing molecular weights (before and after deglycosylation) and distinct peptide maps.
哺乳动物A2 - 腺苷受体结合亚基(A2AR)可用光亲和交联配体125I - 2 - [4 - [2 - [2 - [(4 - 氨基苯基)甲基羰基氨基]乙基氨基羰基]乙基]苯基]乙基氨基 - 5'-N - 乙基羧酰胺腺苷进行共价标记来可视化,或者直接用本文所述的叠氮化物衍生物进行可视化。在十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳上,构成A2 - 腺苷受体结合亚基的蛋白质迁移率为45,000的相对分子质量。在本研究中,通过部分肽图以及用外切糖苷酶和内切糖苷酶处理后,比较了来自牛脑的放射性标记的A1 - 和A2 - 腺苷受体结合亚基的糖蛋白。使用两种不同蛋白酶的肽图显示,通过二维凝胶电泳,A1 - 和A2 - 腺苷受体结合亚基没有共同的肽片段。用内切糖苷酶F处理标记的A2AR会产生一个相对分子质量为38,000的单一标记肽,没有中间肽,这表明存在一条单一的N - 连接碳水化合物链。标记的A2AR对神经氨酸酶敏感,凝胶电泳迁移率增加证明了这一点,这表明受体含有含有末端唾液酸的聚糖成分。用α - 甘露糖苷酶处理标记的A2AR会显示出两种不同的A2AR群体,其中一种对该酶敏感,另一种则具有抗性。两种外切糖苷酶连续处理的非加和性表明,A2AR存在异质性群体,含有复杂型或高甘露糖型碳水化合物链。这些数据表明,A2AR是一种相对分子质量为45,000的糖蛋白,具有一条复杂型或高甘露糖型的单一碳水化合物链。此外,A1 - 和A2AR是不同的糖蛋白,这从它们不同的分子量(去糖基化前后)和不同的肽图可以证明。